专题报道:呼吸系统疾病

英国胸科协会改良肺炎评分及血清白细胞介素-6、降钙素原/白蛋白水平与重症肺炎患者预后的关系

  • 吴春明 ,
  • 程文 ,
  • 张正国 ,
  • 江燕 ,
  • 孙军
展开
  • 1.黄山市人民医院,呼吸与危重症医学科,(安徽 黄山 245000 )
    2.黄山市人民医院,检验科,(安徽 黄山 245000 )
    3.宣城市人民医院呼吸科 (安徽 宣城 242000 )

收稿日期: 2025-11-27

  修回日期: 2025-12-10

  录用日期: 2025-12-16

  网络出版日期: 2026-03-26

基金资助

安徽省临床医学研究转化专项项目(202204295107020058)

Relationship between CURB-65 score, serum IL-6, PCT/ALB ratio and prognosis in patients with severe pneumonia

  • Chunming WU ,
  • Wen CHENG ,
  • Zhengguo ZHANG ,
  • Yan JIANG ,
  • Jun SUN
Expand
  • 1.Department of Respiratory and Critical Care Medicine,Huangshan City People's Hospital,Huangshan 245000,Anhui,Chin
    a2Department of Laboratory,Huangshan City People's Hospital,Huangshan 245000,Anhui,Chin
    a3Department of Respiratory Medicine,Xuancheng People's Hospital,Xuancheng 242000,Anhui,China

Received date: 2025-11-27

  Revised date: 2025-12-10

  Accepted date: 2025-12-16

  Online published: 2026-03-26

摘要

目的 研究英国胸科协会改良肺炎评分(CURB-65)及血清白细胞介素-6(IL-6)、降钙素原/白蛋白(PCT/ALB)水平与重症肺炎患者预后的关系。 方法 回顾性分析2022年6月至2025年7月黄山市人民医院呼吸与危重症医学科接诊的110例重症肺炎患者(重症组)临床资料,另选择同期就诊的轻症肺炎病例55例(轻症组),收集两组患者一般临床资料、入院时CURB-65评分、血清IL-6、PCT/ALB比值等资料,Pearson法分析CURB-65评分与血清IL-6、PCT/ALB的相关性,对重症肺炎依据CURB-65评分分为低危(n = 34)、中危(n = 53)、高危(n = 23),依据其治疗后28 d预后情况分为预后良好组(n = 80)和预后不良组(n = 30),对比不同病情、不同预后的重症肺炎患者CURB-65评分、血清IL-6、PCT/ALB,二元logistic回归分析重症肺炎患者预后影响因素,绘制ROC评估CURB-65评分、IL-6、PCT/ALB对重症肺炎预后的评估价值。 结果 重症组入院时CURB-65评分、血清IL-6、PCT及PCT/ALB高于轻症组,而ALB低于轻症组(P < 0.05);Pearson相关分析显示,重症肺炎患者血清IL-6、PCT及PCT/ALB与CURB-65评分呈正相关,ALB与CURB-65评分呈负相关(P < 0.05);CURB-65评分为高危患者血清IL-6、PCT/ALB高于低危、中危患者,低危、中危患者IL-6、PCT/ALB差异也有统计学意义(P < 0.05);预后不良组入院时CURB-65评分、IL-6、PCT/ALB高于预后良好组,而ALB低于预后良好组(P < 0.05);二元logistic回归分析显示,CURB-65评分、血清IL-6、PCT/ALB是重症肺炎预后独立危险性因素(P < 0.05);ROC曲线显示,CURB-65评分、血清IL-6、PCT/ALB联合预测重症肺炎死亡的曲线下面积为0.944(0.878 ~ 0.980),高于各指标单独预测(Z = 2.162、6.931、2.168,P < 0.05),且联合时敏感度、特异度分别为92.59%、95.77%,CURB-65评分、血清IL-6、PCT/ALB的截断值分别为4分、26.45 pg/mL、0.79。 结论 CURB-65评分、血清IL-6及PCT/ALB比值升高可用于预测重症肺炎病情,且三者均与患者预后不良有关,CURB-65评分、血清IL-6及PCT/ALB联合对重症肺炎预后有一定预测价值,可结合以上指标筛查高危患者,及时采取干预措施,改善患者预后。

本文引用格式

吴春明 , 程文 , 张正国 , 江燕 , 孙军 . 英国胸科协会改良肺炎评分及血清白细胞介素-6、降钙素原/白蛋白水平与重症肺炎患者预后的关系[J]. 实用医学杂志, 2026 , 42(6) : 923 -929 . DOI: 10.3969/j.issn.1006-5725.2026.06.003

Abstract

Objective To investigate the relationship between the CURB-65 score, serum interleukin-6 (IL-6) level, procalcitonin/albumin (PCT/ALB) ratio and the prognosis of patients with severe pneumonia. Methods A retrospective analysis was conducted on the clinical data of 110 patients with severe pneumonia (severe group) admitted to the Department of Respiratory and Critical Care Medicine, Huangshan City People's Hospital between June 2022 and July 2025. Simultaneously, 55 patients with mild pneumonia (mild group) were recruited. General clinical data, CURB-65 scores upon admission, serum IL-6 levels, and PCT/ALB ratio were gathered. Pearson′s method was employed to analyze the correlation between the CURB-65 score and serum IL-6 as well as the PCT/ALB ratio. Patients with severe pneumonia were classified into the low-risk group (n = 34), intermediate-risk group (n = 53), and high-risk group (n = 23) according to the CURB-65 score. Based on the 28-day prognosis, they were categorized into the favorable prognosis group (n = 80) and unfavorable prognosis group (n = 30). The CURB-65 scores, serum IL-6 levels, and PCT/ALB ratios were compared among patients with different severities and prognoses. Binary logistic regression analysis was employed to identify prognostic factors, and receiver operating characteristic (ROC) curves were plotted to assess the prognostic value of the CURB-65 score, IL-6, and PCT/ALB ratio. Results Upon admission, patients in the severe group exhibited higher CURB-65 scores, serum IL-6 levels, PCT levels, and PCT/ALB ratios, but lower ALB levels compared to those in the mild group (P < 0.05). Pearson correlation analysis indicated that in patients with severe pneumonia, serum IL-6, PCT, and PCT/ALB ratios were positively correlated with the CURB-65 score, whereas ALB was negatively correlated with the CURB-65 score (P < 0.05). High-risk patients had higher serum IL-6 levels and PCT/ALB ratios than both low-risk and intermediate-risk patients. Moreover, significant differences were also observed between low-risk and intermediate-risk patients (P < 0.05). At admission, the unfavourable prognosis group had higher CURB-65 scores, serum IL-6 levels, and PCT/ALB ratios but lower ALB levels than the favourable prognosis group (P < 0.05). Binary logistic regression analysis revealed that the CURB-65 score, serum IL-6 level, and PCT/ALB ratio were independent risk factors for the prognosis of patients with severe pneumonia (P < 0.05). ROC curve analysis indicated that the area under the curve (AUC) of the combination of the CURB-65 score, serum IL-6 level, and PCT/ALB ratio for predicting death in severe pneumonia was 0.944 (95%CI: 0.878 - 0.980), which was greater than that of each individual indicator (Z = 2.162, 6.931, 2.168; P < 0.05). The sensitivity and specificity of the joint prediction were 92.59% and 95.77%, respectively. The cut-off values of the CURB-65 score, serum IL-6 level, and PCT/ALB ratio were 4, 26.45 pg/mL, and 0.79, respectively. Conclusions An elevated CURB-65 score, serum IL-6 level, and PCT/ALB ratio are all associated with the severity and poor prognosis of severe pneumonia. The combination of these three indicators holds predictive value for the prognosis and can be employed to screen high-risk patients, thus facilitating timely intervention and enhancing the prognosis.

参考文献

[1] WU X, SUN T, HE H, et al. Effect of metagenomic next-generation sequencing on clinical outcomes of patients with?severe?community-acquired?pneumonia?in the icu: A multicenter, randomized controlled trial[J]. Chest, 2025, 167(2):362-373. doi: 10.1016/j.chest.2024.07.144 .
[2] ROTINI G, DE MANGOU A, COMBE A, et al. Severe community-acquired pneumonia compared to severe community-acquired Acinetobacter baumannii pneumonia in Reunion Island: A retrospective study[J]. Trop Med Int Health, 2025, 30(1):43-50. doi: 10.1111/tmi.14067 .
[3] CARLOS P, GOMES R, COELHO J, et al. CURB-65 and long-term mortality of community-acquired pneumonia: A retrospective study on hospitalized patients[J]. Cureus, 2023, 15(3):e36052. doi: 10.7759/cureus.36052 .
[4] GELAIDAN A, ALMAIMANI M, ALORFI Y A, et al. Comparative effectiveness of CURB-65 and qSOFA scores in predicting pneumonia outcomes: A systematic review[J]. Cureus, 2024, 16(10): e71394. doi: 10.7759/cureus.71394 .
[5] 张新颜, 安莹波, 董叶子, 等. 早期乳酸/白蛋白比值联合快速序贯器官衰竭评分对社区获得性肺炎脓毒症患者预后的急诊预测价值[J]. 中华危重病急救医学,2025,37(2):118-122. doi: 10.3760/cma.j.cn121430-20240709-00577 .
[6] KAL M, BRZD?K M, CIE?LA E, et al. Effect of reduced saturation and elevated D-dimer and interleukin 6 levels on vessel density and foveal avascular zone in patients with COVID-19 bilateral pneumonia[J]. Adv Clin Exp Med, 2025, 34(8): 1331-1342. doi: 10.17219/acem/191774 .
[7] WANG M, WANG Y, HOU X, et al. Predicting?severe?community-acquired?pneumonia?in adults: A machine learning approach using C-reactive protein to?albumin?ratio[J]. J Thorac Dis, 2025, 17(9):6443-6450. doi: 10.21037/jtd-2024-2252 .
[8] ZHAO J, WANG J, WEI B, et al. Exploration of the clinical parameters as predictive biomarkers and their potential roles in the regulation of inflammation in elderly septic patients with pneumonia[J]. J Inflamm Res, 2025, 18(7):7369-7380. doi: 10.2147/JIR.S523902 .
[9] CALIS AG, KARABOGA B, UZER F, et al. Correlation of?pneumonia?severity?index and?CURB-65?Score?with neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and monocyte/lymphocyte ratio in predicting in-hospital mortality for community-acquired?pneumonia:observational study[J]. J Clin Med, 2025, 14(3):728. doi: 10.3390/jcm14030728 .
[10] 中国医师协会急诊医师分会, 中国急诊专科医联体, 北京急诊医学学会. 急诊成人社区获得性肺炎临床实践指南(2024年版)[J]. 中华急诊医学杂志, 2025, 34(3): 300-317. doi: 10.3760/cma.j.issn.1671-0282.2025.03.006 .
[11] 潘建亮,梁婷婷,侯建华. 支气管肺泡灌洗液细胞学检查联合淋巴细胞免疫分析对卒中相关性肺炎危重患者临床疗效的影响[J]. 中国免疫学杂志,2025,41(7):1763-1767. doi: 10.3969/j.issn.1000-484X.2025.07.032 .
[12] 王敬才, 郭春艳, 杨丽昕, 等. 血清RAGE、HMGB1水平与重症肺炎急性呼吸窘迫综合征发病及IFN-γ/IL-4变化的关系[J]. 实用医学杂志, 2024, 40(4): 515-520. doi: 10.3969/j.issn.1006-5725.2024.04.013 .
[13] MOHAMED F, PRIM B A, ZAMPARINI J, et al. Evaluating the CURB-65 score for in-hospital mortality prediction in COVID-19 patients: Insights into dysglycaemia[J]. BMJ Public Health, 2024, 2(2): e001291. doi: 10.1136/bmjph-2024-001291 .
[14] HUANG L, WENG B, GU X, et al. Performance of various pneumonia severity models for predicting adverse outcomes in elderly inpatients with community-acquired pneumonia[J]. Clin Microbiol Infect, 2024, 30(11):1426-1432. doi: 10.1016/j.cmi. 2024.07.008 .
[15] SUN Y, WANG H, GU M, et al. EMR combined with CRB-65 superior to CURB-65 in predicting mortality in patients with community-acquired pneumonia[J]. Infect Drug Resist, 2024, 17(1):463-473. doi: 10.2147/IDR.S443045 .
[16] 杨力航,刘小令,李晶慧,等. 2型糖尿病合并社区获得性肺炎住院患者短期死亡风险预测模型的构建[J]. 中华糖尿病杂志,2023,15(11):1068-1075. doi: 10.3760/cma.j.cn115791-20230924-00185 .
[17] SRINIVAS S, NAHUM K, GILLIAM C, et al. Ventilator-associated pneumonia predicts severe cognitive disability in severe traumatic brain injury[J]. Surg Infect (Larchmt), 2025, 26(5):279-285. doi: 10.1089/sur.2024.208 .
[18] XU T, YAN S, HUANG S, et al. The value of IL-6, D-D, and white blood cell tests in the diagnosis of severe pneumonia[J]. Int Arch Allergy Immunol, 2025, 186(9):889-895. doi: 10.1159/000544042 .
[19] HUANG X, QIN H, ZHANG R, et al. Neutrophils?are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma?pneumoniae?pneumonia[J]. Respir Res, 2025, 26(1):92. doi: 10.1186/s12931-025-03167-z .
[20] 李鑫盼, 方懿, 邱俊. CD3+/CD4+T淋巴细胞水平及中性粒细胞与淋巴细胞比值在放射性肺炎中的预测价值[J]. 实用医学杂志,2024,40(20): 2923-2928. doi: 10.3969/j.issn.1006-5725.2024.20.017 .
[21] PIATTINI F, SIDIROPOULOS N D, BEREST I, et al. IL-6 mediates defense against influenza virus by promoting protective antibody responses but not innate inflammation[J]. Mucosal Immunol, 2025, 18(3): 596-606. doi: 10.1016/j.mucimm. 2025. 02.001 .
[22] ZHOU J R, LIAO Y, CAO L Q, et al. Interleukin 6 is significantly increased in severe pneumonia after allo-hematopoietic stem cell transplantation and might induce lung injury via IL-6/sIL-6R/JAK1/STAT3 pathway[J]. J Infect Dis, 2025, 232(1):113-126. doi: 10.1093/infdis/jiaf041 .
[23] HIGASHIKAWA T, ITO T, MIZUNO T, et al. A new predictive tool consolidating CURB-65 with procalcitonin and albumin to assess short-term mortality in hospitalized elderly patients with infectious disease: A retrospective study of a patient cohort[J]. Medicine, 2022, 101(46):e31614. doi: 10.1097/MD. 0000000000031614 .
[24] 付玉茹, 孙振康, 刘成, 等. C反应蛋白/白蛋白比值与重症肺炎患者病情严重程度的关系及其对28 d死亡风险的预测价值[J]. 解放军医学杂志, 2025, 50(3): 309-317. doi: 10.11855/j.issn.0577-7402.0345.2024.1215 .
[25] XIAO X, HONG Y, WANG S, et al. Diagnostic value of plasma heparin-binding protein and the heparin-binding protein-to-albumin ratio in patients with community-acquired Pneumonia: A retrospective study[J]. BMC Infect Dis, 2023, 23(1):777. doi: 10.1186/s12879-023-08762-3 .
[26] 冯苗, 程盼盼, 姚孟英. 重症肺炎患者发生多重耐药菌感染危险因素分析及模型构建[J]. 中国抗生素杂志, 2025, 50(2): 225-234. doi: 10.3969/j.issn.1001-8689.2025.02.015 .
[27] 杨博文, 苑萌, 韩彩玲, 等. 尿素/白蛋白、CURB-65评分联合急诊感染三项预测重症肺炎患者预后不良价值分析[J]. 临床误诊误治,2024, 37(3): 65-71. doi: 10.3969/j.issn.1002-3429. 2024.03.014 .
[28] 高斯宇, 张盛, 陈曦, 等. 重症肺炎并发呼吸衰竭预测模型的构建[J]. 中国临床医学, 2025, 32(3): 449-457. doi: 10.12025/j.issn.1008-6358.2025.20250102 .
文章导航

/